[Serum neopterin in dilated cardiomyopathy]

Area of Science:

• Cardiology
• Immunology
• Biochemistry

Background:

• Dilated cardiomyopathy (DCMP) is a serious cardiac condition.
• Myocarditis, inflammation of the heart muscle, can be a complication or cause of DCMP.
• Biomarkers for diagnosing myocarditis in DCMP patients are crucial.

Purpose of the Study:

• To investigate the levels of neopterine and beta 2-microglobulin in patients with dilated cardiomyopathy.
• To assess the correlation between these biomarkers and the presence of myocardial inflammation.
• To evaluate the diagnostic utility of neopterine in identifying myocarditis in DCMP.

Main Methods:

• Radioimmunoassay (RIA) was employed to quantify serum neopterine and beta 2-microglobulin levels.
• Serum samples were analyzed from 43 patients diagnosed with DCMP and compared to healthy donors.
• Endomyocardial biopsy was used to assess myocardial inflammation in a subset of patients.

Main Results:

• DCMP patients exhibited significantly higher mean neopterine levels (11.25 nM/l) compared to donors (5.6 nM/l).
• Elevated neopterine (>9 nM/l) was found in 55% of DCMP patients, rising to 81% in those with confirmed myocardial inflammation.
• A positive correlation was observed between elevated neopterine and beta 2-microglobulin levels in DCMP patients.

Conclusions:

• Neopterine measurement is recommended for laboratory diagnosis of myocarditis in DCMP patients.
• Elevated neopterine and beta 2-microglobulin suggest an inflammatory process, possibly linked to hyperinterferonemia.
• Neopterine serves as a valuable biomarker for assessing myocardial inflammation in the context of DCMP.